Daily News

» disease/medicine

Most Recent

image: Cell Transplant Trial for Spinal Injury Is Safe

Cell Transplant Trial for Spinal Injury Is Safe

By Ruth Williams | June 1, 2018

The first human experiment with neural precursor cells implanted to treat chronic spinal cord injury suggests the procedure is safe, and hints at a small benefit.  

0 Comments

The extracellular matrix appears to inhibit regeneration; but scientists debate whether heart muscle really comes back.  

0 Comments

image: Preterm Labor May Be Sparked by Fetal Immune Reaction

Preterm Labor May Be Sparked by Fetal Immune Reaction

By Ruth Williams | April 25, 2018

Immune cells targeting maternal antigens are abundant in the blood of premature infants, suggesting fetal intolerance of mom may instigate early labor.  

0 Comments

image: Social Dominance Comes At a Cost

Social Dominance Comes At a Cost

By Richard Kemeny | March 5, 2018

Dominant male mammals are particularly at risk of infection by parasites.

5 Comments

Patients with the rare autoimmune condition, highlighted in the Oscar-nominated film The Big Sick, currently have limited treatment options.

0 Comments

Testing treatments on mini tumors may save time in identifying which therapies work best, a new study shows.   

4 Comments

image: Viruses Related to Zika May Also Harm Fetuses

Viruses Related to Zika May Also Harm Fetuses

By Ruth Williams | January 31, 2018

Studies in mice suggest that other flaviviruses, such as West Nile virus and Powassan virus, may cause birth defects, too. 

0 Comments

image: Immune Checkpoint Found Lacking in Type 1 Diabetes

Immune Checkpoint Found Lacking in Type 1 Diabetes

By Ruth Williams | November 15, 2017

Boosting levels of a the immunosuppressive protein PD-L1 in blood stem cells halts diabetes in a mouse model of the disease.

0 Comments

image: Child Receives Transgenic Skin Over Most of His Body

Child Receives Transgenic Skin Over Most of His Body

By Ruth Williams | November 8, 2017

A combination gene-and-cell therapy has given a boy with a grievous skin disease a new lease on life, and has resolved a dermatology debate to boot.

0 Comments

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.

1 Comment

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. “Public” T-Cell Receptors From Resistant People Fend Off HIV